Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

GERON CORPORATION (GERN)

18
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/15/2014 09/16/2014 09/17/2014 09/18/2014 09/19/2014 Date
2.38(c) 2.34(c) 2.34(c) 2.31(c) 2.25(c) Last
2 212 220 1 549 737 1 013 628 1 496 170 4 121 826 Volume
-3.25% -1.68% 0.00% -1.28% -2.60% Change
More quotes
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
Surperformance© rating of Geron Corporation
Trading Rating : Investor Rating :
More about the company
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1,39 M
EBIT 2014 -35,8 M
Net income 2014 -35,4 M
Debt 2014 -
Yield 2014 -
Sales 2015 1,31 M
EBIT 2015 -42,8 M
Net income 2015 -42,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 254x
Capi. / Sales 2015 270x
Capitalization 353 M
More Financials
Latest news on GERON CORPORATION
09/05 Leading Health Care Stock for Small-Cap Stars is Stereotaxis Inc (STXS) for S..
08/11 GERON : Reports Second Quarter 2014 Financial Results
08/05 GERON : to Assume Sponsorship of Myelofibrosis IST and IND
08/05 GERON : Entry into a Material Definitive Agreement, Other Events (form 8-K)
08/01 GERON : Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharm..
07/30 GERON : Patent Issued for Compounds Having Anti-Adhesive Effects on Cancer Cells
07/30 GERON : Announces Conference Call to Discuss Second Quarter 2014 Financial Resul..
07/29 GERON : Asterias Biotherapeutics to Hold Investor Webcast
07/22 GERON CORPORATION : Spin off
07/21 GERON : Other Events (form 8-K)
06/13 GERON : GERN) Gains After FDA Green Lights Imetelstat Trial Resumption
06/13 GERON : GERN) (Biotech Winner of Day)
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
Geron Corporation : Income Statement Evolution
More Financials
EPS Revisions
Geron Corporation : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF